Psychiatric disorders and functional impairment in patients with persistent dizziness by KROENKE, K, LUCAS, C. A, ROSENBERG, M. L, SCHEROKMAN, B. J

Get full text

Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials by Goodkin, D E, Priore, R L, Wende, K E, Campion, M, Bourdette, D N, Herndon, R M, Fischer, J S, Jacobs, L D, Cookfair, D L, Rudick, R A, Richert, J R, Salazar, A M, Granger, C V, Simon, J H, Alam, J J, Bartoszak, D M, Braiman, J, Brownscheidle, C M, Coats, M E, Cohan, S L, Dougherty, D S, Kinke, R P, Mass, M K, Munschauer, F E, Pullicino, P M, Scherokman, B J, Weinstock-Guttman, B, Whitham, R H

Get full text

Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis by Rudick, Richard A., Cookfair, Diane L., Simonian, Nancy A., Ransohoff, Richard M., Richert, John R., Jacobs, Lawrence D., Herndon, Robert M., Salazar, Andres M., Fischer, Jill S., Granger, Carl V., Goodkin, Donald E., Simon, Jack H., Bartoszak, David M., Bourdette, Dennis N., Braiman, Jonathan, Brownscheidle, Carol M., Coats, Michael E., Cohan, Stanley L., Dougherty, David S., Kinkel, Revere P., Mass, Michele K., Munchsauer, Frederick E., O'Reilly, Kathy, Priore, Roger L., Pullicino, Patrick M., Scherokman, Barbara J., Wende, Karl, Weinstock-Guttman, Bianca, Whitham, Ruth H.

Get full text

A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics... by Jacobs, LD, Cookfair, DL, Rudick, RA, Herndon, RM, Richert, J R, Salazar, AM, Fischer, JS, Goodkin, DE, Granger, CV, Simon, JH, Emrich, LJ, Bartoszak, DM, Bourdette, DN, Braiman, J, Brownscheidle, CM, Coats, ME, Cohan, SL, Dougherty, DS, Kinkel, RP, Mass, MK, Munschauer, FE, Priore, RL, Pullicino, PM, Scherokman, BJ, Weinstock-Guttman, B, Whitham, RH

Get full text

One-year outcome for patients with a chief complaint of dizziness by KROENKE, K, LUCAS, C, ROSENBERG, M. L, SCHEROKMAN, B, HERBERS, J. E

Get full text

Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials by Goodkin, D.E., Priore, R.L., Wende, K.E., Campion, M., Bourdette, D.N., Herndon, R.M., Fischer, J.S., Jacobs, L.D., Cookfair, D.L., Rudick, R.A., Richert, J.R., Salazar, A.M., Granger, C.V., Simon, J.H., Alam, J.J., Bartoszak, D.M., Braiman, J., Brownscheidle, C.M., Coats, M.E., Cohan, S.L., Dougherty, D.S., Kinkel, R.P., Mass, M.K., Munschauer III, F.E., Pullicino, P.M., Scherokman, B.J., Weinstock-Guttman, B., Whitham, R.H.

Get full text